Northern Trust
IMNM icon

Northern Trust’s Immunome IMNM Stock Holding History

Northern Trust’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Buy
968,346
+69,200
+8% +$1.48M ﹤0.01% 1788
2026
Q1 		$19.7M Buy
899,146
+70,445
+9% +$1.57M ﹤0.01% 1691
2025
Q4 		$17.8M Buy
828,701
+122,186
+17% +$2.14M ﹤0.01% 1745
2025
Q3 		$8.27M Buy
706,515
+14,958
+2% +$149K ﹤0.01% 2222
2025
Q2 		$6.43M Sell
691,557
-6,844
-1% -$56.1K ﹤0.01% 2323
2025
Q1 		$4.7M Buy
698,401
+181,910
+35% +$1.75M ﹤0.01% 2443
2024
Q4 		$5.49M Buy
516,491
+43,146
+9% +$521K ﹤0.01% 2456
2024
Q3 		$6.92M Buy
473,345
+303,096
+178% +$4.31M ﹤0.01% 2289
2024
Q2 		$2.06M Buy
170,249
+34,761
+26% +$544K ﹤0.01% 2882
2024
Q1 		$3.34M Buy
135,488
+35,260
+35% +$716K ﹤0.01% 2712
2023
Q4 		$1.07M Buy
100,228
+83,763
+509% +$696K ﹤0.01% 3293
2023
Q3 		$137K Sell
16,465
-245
-1% -$1.8K ﹤0.01% 3930
2023
Q2 		$132K Sell
16,710
-88
-0.5% -$481 ﹤0.01% 3962
2023
Q1 		$83.8K Hold
16,798
– – ﹤0.01% 4120
2022
Q4 		$37.1K Hold
16,798
– – ﹤0.01% 4356
2022
Q3 		$75K Hold
16,798
– – ﹤0.01% 4209
2022
Q2 		$54K Hold
16,798
– – ﹤0.01% 4381
2022
Q1 		$95K Hold
16,798
– – ﹤0.01% 4355
2021
Q4 		$218K Hold
16,798
– – ﹤0.01% 4170
2021
Q3 		$409K Buy
+16,798
New +$293K ﹤0.01% 3845
2021
Q2 		– Sell
-27,114
Closed -$918K – 4611
2021
Q1 		$918K Buy
27,114
+1,827
+7% +$45.4K ﹤0.01% 3618
2020
Q4 		$245K Buy
+25,287
New +$295K ﹤0.01% 3920

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Northern Trust's IMNM Position: Q2 2026 in Review

Northern Trust increased its Immunome (IMNM) stake by 7.7% in Q2 2026, buying an estimated $1.48M and bringing the position to 968,346 shares worth $20.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1788.

Northern Trust first reported a position in IMNM in Q4 2020 and has held it in 22 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Northern Trust held 968,346 shares of Immunome worth $20.5M as of Q2 2026.
  • Northern Trust bought 69,200 Immunome shares in Q2 2026, an estimated $1.48M.
  • Immunome made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1788 holding.
  • Northern Trust first reported a position in Immunome in Q4 2020 and has held it in 22 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.